If you’re trying to hit launch and revenue targets, make more informed NPD portfolio decisions, and best leverage the R&D resources you have available, it can feel like you’re paddling upstream if you don’t have the right tools and processes in place. Luckily, there are leaders in the industry who have successfully gone before you to pave the way and are willing to share their experience.
In the webinar, Maximizing the Value of Your NPD Portfolio – Leveraging the Full Potential of Your Resources to Deliver Products On Time, one such pioneer shared his recent journey and the value they derived from implementing PPM for NPD.
During the Q&A session with Geoffrey Daniel, Head of Research and Development at Coloplast, he provided some great insights into how they leveraged Innotas to ultimately improve patient quality of life. Adding additional details to this discussion was Planview’s Innovation and NPD Solution Evangelist, Carrie Nauyalis. Here is a quick recap of some of the thoughtful questions posed by the audience and answered by Coloplast:
Q: At Coloplast, do you have all R&D resources in one instance of Innotas that includes all of the cross-functional groups that support R&D? Does this allow you to look at resource capacity across all support groups?
A: Yes, we actually do have all R&D and all cross-functional groups in one instance. One of the goals with how we implemented was to break down silos between the groups. We wanted to be transparent so any manager could look across any function to understand what groups were working on. This allows everyone to work off the same priority list and improves communication. We’ve had trouble in the past with groups hunkering down and being isolated, so we wanted to break that down.
Q: Based on your experience, do you have any tips on how to raise awareness with executive leadership for the need of a PPM tool like Innotas?
A: The number one indicator that will catch the eye of management is whether or not you are completing projects on time. If a number of projects are not moving forward or your organization is regularly missing milestones, you can easily show that you don’t have the tools you need. This is especially true if the delay is caused by lack of resources. When you can point to the specific resource gaps that are causing projects to be late [along with associated financial targets], executive leadership tends to pay attention. To further support your case for the need for PPM tools, quantify the amount of time wasted on resource planning meetings, discussions, and arguments – this will highlight that you don’t have a good planning process in place.
Q: What if you’re functioning well, but your company is still looking to improve efficiencies?
A: In the spirit of lean product development and other lean techniques, a system like Innotas fits right in with these initiatives to maximize your resources and investments. It shows you the planning that you need to achieve the greatest ROI. [If you need assistance articulating these types of benefits, you can leverage the Innotas ROI Calculator.]
Q: How many Coloplast employees and resources are captured in Innotas?
A: Currently we have around 60 users in Innotas. A portion of that count includes upper management to give them the visibility they need to make decisions. We have around 45 actual working resources that we manage with Innotas as part of our one division within the greater Coloplast.
Q: Can you show product volume via Innotas dashboards if you’re looking to increase volume?
A: Yes, Innotas is completely configurable so you can track whatever you like – revenue, volume, margin – it’s all up to you. There are a lot of out-of-the-box metrics that focus on NPD to choose from, but whatever you track can be reported and rolled up in any way you like. Planview consultants can show you how to adjust your reports and then apply lessons learned, tweak the metrics, and report progress.
Q: Can you include views to show cost savings rather than revenue?
A: Yes, absolutely. Again, it is configurable. Cost savings is becoming a very popular metric for evaluating portfolios these days for both IT and Product Development.
Q: Do you have confidential projects at Coloplast and how do you limit access and visibility from other groups using Innotas?
A: Yes, we do use Innotas to track our confidential projects. These projects have “code names” and we track them with less detail than a non-confidential project due to transparency we provide all of our users. We still perform resource tracking on confidential projects to determine capacity and availability, but these projects aren’t statused, scheduled, or categorized the same. There are also ways to configure the system to parse out those confidential projects, but this method supported our goal of transparency.
Q: How quickly did you get users into the system or does it remain a centralized administration?
For us, it was pretty quick. We launched in January and there was definitely a curve of onboarding users – some people were in it and doing various activities within days and others took a few weeks. We offered a couple of training sessions and offered one-on-one walkthroughs. We were fully up and running within a month.
If you want to learn how your company can focus your resources on the most valuable NPD projects and improve time to market, watch this short Innotas for NPD demo and get started maximizing the value your NPD portfolio today!